The Supreme Court of India has dismissed a Public Interest Litigation (PIL) challenging the HPV vaccination drive for adolescent girls, upholding the guidelines set by the World Health Organization (WHO).

  • Supreme Court dismissed a PIL alleging HPV vaccines affect fertility.
  • The court emphasized adherence to WHO global health prescriptions.
  • Petitioner UHO raised concerns over 'informed consent' and adverse event monitoring.

The Supreme Court on Thursday dismissed a Public Interest Litigation (PIL) that claimed the Human Papillomavirus (HPV) vaccine could negatively impact fertility. The plea sought stringent safeguards and a monitoring mechanism for the rollout of the nationwide vaccination programme targeting adolescent girls.

A three-judge bench, presided over by CJI Surya Kant and comprising Justices Joymalya Bagchi and V Mohana, expressed skepticism toward the claims made by the Universal Health Organisation (UHO). The Delhi-based forum of doctors and academics alleged that the vaccination exercise was being conducted without "adequate informed parental consent."

Read Also:Noida Bus Rape Case: 8 Challans Issued in July, No Background Check for Accused Revealed

Why This Matters

BozokMedia analysis shows that this ruling prevents a potential wave of vaccine hesitancy that could have derailed one of India's most critical preventative health drives. By validating the WHO's role, the Court has effectively shielded the national health infrastructure from litigious delays based on unsubstantiated medical fears.

During the proceedings, Advocate Shivan Raghuwanshi, representing UHO, clarified that the organization is not "anti-vaccine." Instead, the contention centered on the implementation process. The petitioner argued that there is a lack of a robust adverse event mechanism and a necessary compensation scheme for any negative reactions to the vaccine.

Judicial deference to global health bodies like the WHO is standard when national health policies are aligned with proven scientific consensus.

Justice Bagchi was critical of the medical professionals behind the plea, stating that since the World Health Organisation (WHO) prescribes the HPV vaccine as part of its social medicine endeavour, it was questionable why doctors would approach the court with such a petition.

Historical Background: Cervical cancer remains a significant health burden for women in India. The HPV vaccine is globally recognized as a primary tool to prevent the onset of this cancer by targeting the virus that causes most cases. The Indian government's push for widespread vaccination is part of a broader strategy to reduce maternal mortality and cancer rates.

Did You Know?: The HPV vaccine is one of the few vaccines in existence that can effectively prevent a specific type of cancer from developing later in life.

Frequently Asked Questions

1. What was the primary concern of the UHO petition?
The petition alleged that the vaccine affects fertility and that parents were not being properly informed before their daughters were vaccinated.

2. What was the Court's final stance?
The Court dismissed the plea, highlighting that the vaccine is recommended by the WHO and allowing the petitioner to withdraw the case.